L. Quercioli

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
L D Quercioli, L Quercioli, L. Quercioli, Leonardo Quercioli
Publication record
39 papers · 2,167 citations · H-index 23

PAPERS

rTMS in resistant mixed states: an exploratory study.
201424 citationsauthor #4
Low-Frequency rTMS over Right Dorsolateral Prefrontal Cortex in the Treatment of Resistant Depression: Cognitive Improvement Is Independent from Clinical Response, Resting Motor Threshold Is Related to Clinical Response
201252 citationsauthor #6
Contents Vol. 65, 2012
20120 citationsauthor #9
rTMS age-dependent response in treatment-resistant depressed subjects: a mini-review
201253 citationsauthor #8
Repetitive transcranial magnetic stimulation (RTMS) as augmentation treatment in bipolar mixed state
20110 citationsauthor #5
Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression?
2010104 citationsauthor #8
Cognitive event-related potentials differentiate schizophrenia with obsessive-compulsive disorder (schizo-OCD) from OCD and schizophrenia without OC symptoms.
200929 citationsauthor #4
S.21.04 Treatment-resistant obsessive-compulsive disorder
20070 citationsauthor #4
Clinical Practice and Epidemiology in Mental Health Resistant Social Anxiety Disorder Response to Escitalopram
200620 citationsauthor #2
Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines.
2006369 citationsauthor #2
Clinical Practice and Epidemiology in Mental Health
200667 citationsauthor #2
The Shorter PROMIS Questionnaire and the Internet Addiction Scale in the Assessment of Multiple Addictions in a High-School Population: Prevalence and Related Disability
2006209 citationsauthor #3
Serotonin Dysfunction in Pathological Gamblers: Increased Prolactin Response to Oral m-CPP Versus Placebo
200690 citationsauthor #3
Dr. Pallanti and Colleague Reply
20051 citationsauthor #2
P.1.030 Mirtazapine augmentation of citalopram accelerates response in OCD patients without comorbid depression: A pilot study
20040 citationsauthor #1
Social anxiety in outpatients with schizophrenia: a relevant cause of disability.
2004270 citationsauthor #2
Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.
200496 citationsauthor #2
Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.
200282 citationsauthor #2
Lithium and valproate treatment of pathological gambling: a randomized single-blind study.
2002141 citationsauthor #2
Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder.
200178 citationsauthor #3
Alternative route of administration and titration of SRIs in anxious resistant patients: Two day-hospital experiences
20010 citationsauthor #2
Shame and Psychopathology
200014 citationsauthor #2
CNS volume 5 issue 9 Cover and Front matter
20000 citationsauthor #8
SSRIs in the treatment of premenstrual dysphoric disorder. Nefazodone: An open trial
20000 citationsauthor #2
Effect of neuroleptics on subjective cognitive disturbances and insight in schizophrenia
20002 citationsauthor #2
Social Anxiety and Premorbid Personality Disorders in Paranoid Schizophrenic Patients Treated With Clozapine
200023 citationsauthor #2
The emergence of social phobia during clozapine treatment and its response to fluoxetine augmentation.
199950 citationsauthor #2
Effects of clozapine on awareness of illness and cognition in schizophrenia.
199951 citationsauthor #2
Citalopram for treatment-resistant obsessive-compulsive disorder
199955 citationsauthor #2
Social phobia symptoms emerged during clozapine treatment: 4 case reports
19990 citationsauthor #2
Basic symptoms and P300 abnormalities in young schizophrenic patients.
199923 citationsauthor #2
Cognitive subjective disturbances of schizophrenia: Effect of atypical neuroleptics
19991 citationsauthor #2
Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder.
199987 citationsauthor #2
Eye movement abnormalities in anorexia nervosa.
199828 citationsauthor #2
Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder.
199841 citationsauthor #4
Relapse in young paranoid schizophrenic patients: a prospective study of stressful life events, P300 measures, and coping.
199787 citationsauthor #2
Smooth-pursuit eye movement and saccadic intrusions in obsessive-compulsive disorder.
199617 citationsauthor #7
Depth perception in schizophrenia
19940 citationsauthor #4
Influence of DEAE-dextran on plaque production by Semliki forest virus.
19684 citationsauthor #3

TIMELINE

1968 4 citations

1994 0 citations

1996 17 citations

1997 87 citations

1998 69 citations

1999 267 citations

2000 39 citations

2001 78 citations

2002 223 citations

2004 366 citations

2005 1 citations

2006 755 citations

2007 0 citations

2009 29 citations

2010 104 citations

2011 0 citations

2012 105 citations

2014 24 citations

L. Quercioli

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT